Skip to main content
HR 163 111th Congress House Health Administrative law and regulatory procedures Administrative remedies Department of Health and Human Services Drug safety, medical device, and laboratory regulation Income tax credits Internet and video services Internet, web applications, social media Licensing and registrations Prescription drugs Trade restrictions

Prescription Drug Affordability Act

Introduced: January 6, 2009 See on congress.gov
 Everywhere this bill has been 6 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jan 14, 2009
Referred to the Subcommittee on Health.
Jan 6, 2009
Referred to House Ways and Means
Jan 6, 2009
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jan 6, 2009
Referred to House Energy and Commerce
Jan 6, 2009
Sponsor introductory remarks on measure. (CR E5)
Jan 6, 2009
Introduced in House
 Plain-English summary Congressional Research Service

Prescription Drug Affordability Act - Amends the Internal Revenue Code to allow a nonrefundable tax credit for 80 percent of the amount paid for a prescribed drug during the taxable year (and not compensated for by insurance or otherwise) by a taxpayer who has attained social security retirement age.

Amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to repeal provisions restricting the importation of prescription drugs. Allows a person who meets applicable legal requirements to be an importer of prescription drugs upon application to the Secretary of Health and Human Services. Requires the Secretary to approve such an application if the drug meets all FFDCA requirements for admission into the United States, including that the drug has been approved by the Food and Drug Administration (FDA) and is not adulterated or misbranded.

Prohibits the Secretary from taking any action against any of the persons involved with the interstate sale of a prescription drug through an Internet site if: (1) the sale was made in compliance with FFDCA, the Controlled Substances Act, and applicable state laws; and (2) accurate information regarding compliance with such laws is posted on the Internet site.

What's happening now January 14, 2009

Referred to the Subcommittee on Health.

 Committees of jurisdiction 3